Want to join the conversation?
Mark Schoenebaum of Evercore ISI asks what is $AMGN's appetite for an at-risk Humira biosimilar launch. CEO Bob Bradway said the company is not going to comment on its launch plans for Humira. He added that the next step is for $AMGN to get a regulatory approval for its molecule and that is what the company is focused on securing.
Planned to give Apple AirPods as a Christmas present to my beloved one. Looks like I need backup plans as $AAPL is delaying the release..!!
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.